https://www.mdlinx.com/internal-medicine/medical-news-article/2017/08/25/discharge-care-acute-stroke-intervention-tia/7281677/?
BMJ Open
Cadilhac DA, et al.
In order to improve the
discharge care in patients admitted with acute stroke or transient
ischaemic attack, this study intended to formulate and pilot test an
interdisciplinary, organisational intervention. An effective and
sustained improvement could be attained via a staged and peer–informed,
organisational intervention. Additional application and research on a
larger scale were necessitated.
Methods
- This research was performed at the acute care public hospitals in Queensland, Australia (n=15).
- 15 hospitals were ranked against a benchmark based on a composite outcome of three discharge care processes.
- The participants took part in a focus group to elicit their success factors.
- Two pilot hospitals then participated in the organisational intervention that was designed with experts and consumers.
- The enrollment constituted hospital clinicians involved in discharge care for stroke and patients admitted with acute stroke or transient ischaemic attack.
- A four-stage, multifaceted organisational intervention involved data reviews, education and facilitated action planning.
- The primary measures were 3 discharge processes collected in Queensland hospitals within the Australian Stroke Clinical Registry to select study hospitals: (1) discharge care plan; (2) antihypertensive medication prescription and (3) antiplatelet medication prescription (ischaemic events only).
- Primary measure was the composite outcome.
- Secondary measures included individual adherence changes for each discharge process; sensitivity analyses.
- A comparison was carried out of the performance outcomes , 3 months prior to the intervention (preintervention), 3 months postintervention and at 12 months (sustainability).
Results
- An inspection was conducted of the findings from 1289 episodes of care from the two pilot hospitals.
- Improvements from preintervention adherence were: Antiplatelet therapy (88%vs96%, p=0.02); antihypertensive prescription (61%vs79%, p<0.001); discharge planning (72%vs94%, p<0.001); composite outcome (73%vs89%, p<0.001).
- An insignificant decay effect was reported over the 12-month sustainability period (composite outcome: 89% postintervention vs 85% sustainability period, p=0.08).
No comments:
Post a Comment